aztreonam has been researched along with Bronchial Pneumonia in 3 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam (AZT) was given intravenously to 20 children with the following acute bacterial infections: 13 cases of bronchopneumonia, 5 cases of urinary tract infection, 1 case of cervical lymphadenitis with acute tonsillitis and 1 case of acute enteritis." | 3.67 | [Clinical experience with aztreonam in the pediatric field]. ( Aihara, R; Kobashi, H; Nishioka, A; Okamoto, T; Oohara, K, 1985) |
| "Aztreonam is a novel antimicrobial agent belonging to the monobactam class of antibiotics." | 1.27 | Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa. ( Neu, HC; Scully, BE, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aquino, G | 1 |
| Barbera, S | 1 |
| Romano, F | 1 |
| Zottola, V | 1 |
| Scully, BE | 1 |
| Neu, HC | 1 |
| Kobashi, H | 1 |
| Aihara, R | 1 |
| Nishioka, A | 1 |
| Oohara, K | 1 |
| Okamoto, T | 1 |
3 other studies available for aztreonam and Bronchial Pneumonia
| Article | Year |
|---|---|
[Use of aztreonam in the treatment of acute and flare-ups of chronic infectious bronchopneumopathies].
Topics: Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Bronchial Diseases; Bronchopneumoni | 1988 |
Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infectio | 1985 |
[Clinical experience with aztreonam in the pediatric field].
Topics: Acute Disease; Age Factors; Aztreonam; Bacteria; Bronchopneumonia; Child; Child, Preschool; Drug Eva | 1985 |